Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03924700
Other study ID # BESS_002
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 28, 2019
Est. completion date December 28, 2021

Study information

Verified date March 2022
Source Seoul National University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is to compare the clinical outcome between the biportal endoscopic discectomy and microdiscectomy in herniated intervertebral disc of lumbar spine


Recruitment information / eligibility

Status Completed
Enrollment 64
Est. completion date December 28, 2021
Est. primary completion date November 30, 2021
Accepts healthy volunteers No
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria: - patients aged between 20 and 80 - patients who has radiating pain (VAS >=40) on lower extremities with HIVD - patients who required one-level discectomy between L1 and S1 - those who (only if a signature was obtainable), or whose legal guardian, fully understood the clinical trial details and signed the informed consent form Exclusion Criteria: - Revision surgery - Over spondylolisthesis Gr II - Degenerative lumbar scoliosis (Cobb angle >20) - patients with a history of other spinal diseases (compression fracture, spondylitis, tumor) - women with positive pregnancy tests before the trial or who planned to become pregnant within the following 3 years - patients with a history of malignant tumor or malignant diseases (but the cases of cured disease with no relapse for the past 5 years were included in the present study) - patients with mental retardation or whose parents or legal guardians were older or had mental disabilities - other patients viewed as inappropriate by the staff

Study Design


Related Conditions & MeSH terms

  • Lumbar Herniated Intervertebral Disc

Intervention

Procedure:
Biportal endoscopy
Biportal endoscopic spine surgery (BESS)
Microdiscectomy
Using microscope for discectomy

Locations

Country Name City State
Korea, Republic of Chungnam National University Hospital Daejeon
Korea, Republic of Seoul National University Bundang Hospital Seongnam-si Gyounggido

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Oswestry disability index (ODI) The ODI is based on a self-administered questionnaire measuring ''back-specific function.'' The questionnaire comprises 10 items, each with 6 levels of response. Each item is scored from 0 to 5, and the total summation is converted to a 0-100 scale. The ODI scores ranges from 0 to 100, with higher scores indicating severe symptoms.
This is assessed by ODI survey at 1 year after surgery
at 1 year after surgery
Secondary Change from baseline Oswestry disability index (ODI) The ODI is based on a self-administered questionnaire measuring ''back-specific function.'' The questionnaire comprises 10 items, each with 6 levels of response. Each item is scored from 0 to 5, and the total summation is converted to a 0-100 scale. The ODI scores ranges from 0 to 100, with higher scores indicating severe symptoms. 3, 6, and 12, months, and every year, up to 5 year after operation
Secondary Change from baseline Visual Analog Pain Scale (VAS) VAS is a measurement score that indicates pain severity status. VAS score comprised a 10-cm line with ''none'' (0) on one end of the scale and ''disabling pain'' (10) on the other. 4, 8, 12, 24, 48 hours, 2 weeks, 3, 6, and 12, months, and every year, up to 5 year after operation
Secondary Change from baseline EuroQoL-5 dimension (EQ-5D) value EQ-5D is a standardized instrument developed by the EuroQol Group as a measure of health-related quality of life that can be used in a wide range of health conditions and treatments. The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Rated level can be coded as a number 1 to 5, which indicates having no problems for 1, and having extreme problems for 5. As a result, a person's health status can be defined by a 5-digit number, ranging from 11111 (having no problems in all dimensions) to 55555 (having extreme problems in all dimensions). EQ-5D health states may be converted into a single index value. The index values are a major feature of the EQ-5D instrument, facilitating the calculation of quality-adjusted life years (QALYs) that are used to inform economic evaluations of health care interventions. The value sets are anchored on 11111 = 1 and 55555 = 0 and can therefore be used in QALY calculations. 3, 6, and 12, months, and every year, up to 5 year after operation
Secondary Change from baseline PainDETECT score The painDETECT Questionnaire (PDQ) is a screening tool designed to detect neuropathic pain in patients with chronic low back pain (LBP) based on self-reported pain characteristics. The degree of the seven types of pain quality, the type of pain pattern, and the presence of radiating pain. From the three components of the PDQ, a total score is calculated; a high score indicates that the pain is likely to have a neuropathic component. Scoring is performed using a scoring manual, and results in a final screening score: a score of 0-12 indicates nociceptive pain, 19-38 indicates neuropathic pain, and 13-18 indicates mixed pain. 3, 6, and 12, months, and every year, up to 5 year after operation
Secondary Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 Surgery related adverse events (incidental durotomy, wound infection, re-operation, re-admission) up to 1 month after operation
Secondary Operation duration time (minutes) Intraoperative time in minutes Immediate after operation
Secondary Volume of postoperative drainage (ml) Total drainage after surgery in milli-liter Within 3 days after operation
Secondary Number of participants with complete discectomy After surgery, degree of discectomy was measured using postoperative MRI Within 3 days after operation
Secondary Concentration of creatine phosphokinase level in blood Creatine phosphokinase assessment to measure muscle injury at operation At 2 day after surgery
Secondary Volume of postoperative Fentanyl consumption Total amount of fentanyl consumption after surgery (PCA dose + rescue dose) At 3 days after operation
Secondary Times of hospital stay (hours) Total hospital stay after surgery Within 7 days after operation
Secondary Number of radiographic complications Radiographic complications includes disc degeneration, facet degeneration, re-ruptured disc, back muscle atrophy, kyphotic change, disc rupture... every year, up to 5 year after operation
See also
  Status Clinical Trial Phase
Completed NCT02598232 - The Efficacy and Safety of the 1,414 nm Nd:YAG Laser System for Alleviating Back Pain in a Lumbar Disc Patient Phase 2/Phase 3